18
Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

  • Upload
    dean

  • View
    42

  • Download
    4

Embed Size (px)

DESCRIPTION

Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes. Blood clotting. 1. Platelet aggregation 2. Constriction of injured vessels 3. Fibrin formation. THE CLOTTING CASCADE - A SIMPLE VIEW. FIBRIN FIBRE. FIBRINOGEN - FIBRIN CONVERSION. ~450Å. FIBRINOGEN. - PowerPoint PPT Presentation

Citation preview

Page 1: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

Clinical Aspects of Biochemistry

Proteins and Disease

Blood clotting enzymes

Page 2: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

Blood clotting

1. Platelet aggregation

2. Constriction of injured vessels

3. Fibrin formation

Page 3: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

THE CLOTTING CASCADE - A SIMPLE VIEW

Page 4: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

FIBRIN FIBRE

Page 5: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

FIBRINOGEN - FIBRIN CONVERSION

Page 6: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

FIBRINOGEN

~450ÅFrom Voigt & Voigt

Page 7: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

FIBRINOGEN - POLYPEPTIDE CHAIN ORGANIZATION

From Voigt & Voigt

Page 8: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

FIBRIN AGGREGATION

From Voigt & Voigt

Page 9: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

Transamidase (Factor XIIIa)

Gln

Lys

CROSSLINKING FIBRIN

Page 10: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

From Stryer

Page 11: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

-carboxy glutamic acid (Gla):• ~10 residues near N-terminus of prothrombin• also found in other enzymes of clotting cascade• synthesis requires vitamin K (antagonised by dicoumarol and warfarin)• facilitates binding to Ca2+ and membrane localisation

PROTHROMBIN

Page 12: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

Factor X (Stuart factor)• Glycoprotein. Mr 55,000• L chain (16.5K) and H chain (39K) joined by S-S bridge. ‘Pro’ bit stays attached after activation• Activated by cleavage of 51 residues from N-terminus of H chain by factor IXa + factor VIII + Ca2+ + phospholipid or factor VIIa + tissue factor

Factor IX (Christmas factor)• Glycoprotein. Mr 55,000• ~ 15% of haemophilia• Activated by removal of 11K fragment from factor XIa:

27K

S S

17K

11KIXa:

Page 13: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

FACTOR VIII (antihaemophilia factor)

Lack of factor VIII causes haemophilia A - 70-80% of all haemophiliaProtein of 2351 aas; gene ~186,000 bp:.

Page 14: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

From Stryer

Page 15: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

CONTROL OF CLOTTING

1. Dilution and localisation

2. Antithrombin (58K protein; a serpin)

3. Heparin (sulphated glycosaminoglycan)

4. Protein C (zymogen; activated by thrombin)

5. Thrombomodulin (74K glycoprotein)

[hirudin - leeches]

Page 16: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

INTRINSIC PATHWAY - FEEDBACK

Page 17: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

CLOT LYSIS

Plasmin:• a serine protease (trypsin like) which specifically breaks down fibrin• formed from plasminogen (86K protein), by action of other proteases : urokinase (kidney) or tissue plasminogen activator (tPA)

tPA:

From Stryer

Page 18: Clinical Aspects of Biochemistry Proteins and Disease Blood clotting enzymes

From Stryer